As expectations evolve under EU REACH and ICH S5 (R3) regulations, the validation and acceptance of New Approach Methodologies (NAMs) can help support and strengthen regulatory confidence in their use in developmental and reproductive toxicity (DART) testing.

The ReproTracker® assay is a human induced pluripotent stem cell (hiPSC)-based system used to investigate whether (agro)chemicals or therapeutics interfere with early embryonic development. Whether you’re in early discovery or late-stage development, ReproTracker empowers faster, more confident decision-making and can quantitatively predict teratogenic potential.

Join this expert-led webinar to learn how to:

• Complement traditional in vivo toxicology methods with the validated ReproTracker assay
• Extrapolate animal-derived results compared to humans and ensure regulatory confidence
• Reduce risk and uncertainty in early and late-stage DART testing
• Gain efficiencies in your DART programs through Charles River collaboration with Toxys

You’ll gain practical insights, hear real-world examples, and engage directly with our experts during a live Q&A.

Register for the other webinar in the series:

November 4, 2025: Discover New Approach Methodologies (NAMs) for Your Endocrine Disruptor and DART Programs

Presenters:

Pragati Coder, PhD, DABT
Global Lead, DART, C&C 
Senior Director, DART, Juvenile and Neurotoxicology
Charles River
Scientific Moderator

José Manuel Horcas Nieto, PhD
Director Developmental Toxicology
Toxys
Webinar Presenter

Amer Jamalpoor, PhD, ERT
Chief Scientific Officer
Toxys
Webinar Q&A Panelist

Have a scheduling conflict? Sign up even if you can’t make it; we’ll share the recording after.

Charles River Webinar on ReproTracker
Tuesday, November 11, 2025
11:00 AM EST | 5:00 PM CET | Duration 1 Hour